Bringing Alzheimer’s Blood Tests into Practice: Lessons for Physician Associates
Date: November 12, 12 p.m. ET
Blood-based diagnostics are rapidly advancing and reshaping how Alzheimer’s disease is detected and managed. In this webinar, participants will gain an up-to-date overview of the science behind Alzheimer’s blood tests, the current state of clinical adoption, and practical considerations for implementation. The session will highlight lessons from real-world experience, exploring test access, integration into clinical workflows, and the role physician associates can play in improving early diagnosis, care planning, and patient communication using these emerging tools.
Attendees will leave understanding the current landscape of Alzheimer’s blood tests, including scientific validity, availability, and clinical value; and able to identify practical steps and considerations for integrating blood tests into clinical workflows, from ordering to communicating results.
This webinar is NOT eligible for CME.
Speaker: Madeline Paczynski, MCMSc, PA-C
Paczynski is a PA at the Knight Alzheimer Disease Research Center at Washington University in St. Louis, specializing in the diagnosis and treatment of Alzheimer’s disease and other causes of dementia. She leads the anti-amyloid therapy clinic, where she oversees patient care and safety for emerging treatments such as lecanemab and donanemab. In addition to her clinical work, she is very involved in Alzheimer’s research as a co-investigator and collaborator on multiple clinical trials and clinical research, with a focus on biomarker-driven approaches and novel therapeutic strategies.
Brought to you in partnership with 
.